Literature DB >> 26983956

Prevention programs for chronic kidney disease in low-income countries.

Norberto Perico1, Giuseppe Remuzzi2,3,4.   

Abstract

Chronic kidney disease (CKD) is an important determinant of the poor health outcome for major noncommunicable diseases that are the leading cause of death worldwide. Early recognition with screening programs of CKD and co-morbid conditions, like hypertension, diabetes, or toxic environments, can potentially slow progression to renal failure, improve quality of life and reduce healthcare cost. Effective multimodal tools are available to prevent CKD by managing its risk factors, and to slow or even halt disease progression to end-stage renal failure (ESRF). They can be adapted even to poor-resource settings of low- and middle-income countries for individual at high risk of CKD. CKD is also linked to acute kidney injury (AKI), that in poorest part of Africa, Asia and Latin America is preventable, treatable and often reversible, if managed adequately and in timely manner as proposed by the program "AKI 0by25" launched by the international Society of Nephrology in 2013. In addition to saving lives, prevention programs will create major heath gains, eventually reducing the current health inequity that arises from unaffordable or unobtainable renal replacement therapies in many part of the developing world if ESRF is not prevented.

Entities:  

Keywords:  Awareness; Chronic kidney disease; Prevention programs; Screening

Mesh:

Year:  2016        PMID: 26983956     DOI: 10.1007/s11739-016-1425-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  23 in total

1.  Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease.

Authors:  M J Bottomley; A Kalachik; C Mevada; M O Brook; T James; P N Harden
Journal:  Nephron Clin Pract       Date:  2010-10-15

2.  Acute renal failure: an unacceptable death sentence globally.

Authors:  Giuseppe Remuzzi; Richard Horton
Journal:  Lancet       Date:  2013-12-21       Impact factor: 79.321

Review 3.  Birth weight, malnutrition and kidney-associated outcomes--a global concern.

Authors:  Valerie A Luyckx; Barry M Brenner
Journal:  Nat Rev Nephrol       Date:  2015-01-20       Impact factor: 28.314

4.  International Society of Nephrology's perspective on the emergence of chronic kidney diseases of unknown/undetermined etiology.

Authors:  Giuseppe Remuzzi; Norberto Perico
Journal:  MEDICC Rev       Date:  2014-04       Impact factor: 0.583

5.  Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.

Authors:  Gregorio T Obrador; Guillermo García-García; Antonio R Villa; Ximena Rubilar; Nadia Olvera; Evangelina Ferreira; Margarita Virgen; José Alfonso Gutiérrez-Padilla; Melissa Plascencia-Alonso; Martha Mendoza-García; Salvador Plascencia-Pérez
Journal:  Kidney Int Suppl       Date:  2010-03       Impact factor: 10.545

Review 6.  Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.

Authors:  Giuseppe Remuzzi; Piero Ruggenenti; Norberto Perico
Journal:  Ann Intern Med       Date:  2002-04-16       Impact factor: 25.391

Review 7.  Maintenance Dialysis throughout the World in Years 1990 and 2010.

Authors:  Bernadette Thomas; Sarah Wulf; Boris Bikbov; Norberto Perico; Monica Cortinovis; Karen Courville de Vaccaro; Abraham Flaxman; Hannah Peterson; Allyne Delossantos; Diana Haring; Rajnish Mehrotra; Jonathan Himmelfarb; Giuseppe Remuzzi; Christopher Murray; Mohsen Naghavi
Journal:  J Am Soc Nephrol       Date:  2015-07-24       Impact factor: 10.121

8.  The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.

Authors:  William G Couser; Giuseppe Remuzzi; Shanthi Mendis; Marcello Tonelli
Journal:  Kidney Int       Date:  2011-10-12       Impact factor: 10.612

9.  Role of remission clinics in the longitudinal treatment of CKD.

Authors:  Piero Ruggenenti; Elena Perticucci; Paolo Cravedi; Vincenzo Gambara; Marco Costantini; Sanjib Kumar Sharma; Annalisa Perna; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 10.121

10.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

View more
  14 in total

1.  Chronic kidney disease in low-middle income populations: a call to action for screening and prevention.

Authors:  Anna Paini; Massimo Salvetti; Silvio Caligaris; Francesco Castelli; Maria Lorenza Muiesan
Journal:  Intern Emerg Med       Date:  2018-12-06       Impact factor: 3.397

2.  Chronic disease in the ethnic minority and migrant groups: time for a paradigm shift in Europe.

Authors:  Pietro Amedeo Modesti; Francesco Perticone; Gianfranco Parati; Enrico Agabiti Rosei; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2016-03-28       Impact factor: 3.397

3.  Sodium copper chlorophyllin attenuates adenine-induced chronic kidney disease via suppression of TGF-beta and inflammatory cytokines.

Authors:  Sachin V Suryavanshi; Milind Gharpure; Yogesh A Kulkarni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-05       Impact factor: 3.000

Review 4.  Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from México.

Authors:  Margarita Ibarra-Hernández; Oralia Alejandra Orozco-Guillén; María Luz de la Alcantar-Vallín; Ruben Garrido-Roldan; María Patricia Jiménez-Alvarado; Kenia Benitez Castro; Francisco Villa-Villagrana; Mario Borbolla; Juan Manuel Gallardo-Gaona; Guillermo García-García; Norberto Reyes-Paredes; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2017-10-11       Impact factor: 3.902

5.  A Cross-Sectional Analysis of Dietary Intake and Nutritional Status of Patients on Haemodialysis Maintenance Therapy in a Country of Sub-Saharan Africa.

Authors:  Nyangi A Gityamwi; Kathryn H Hart; Barbara Engel
Journal:  Int J Nephrol       Date:  2021-05-15

Review 6.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening.

Authors:  Cindy George; Amelie Mogueo; Ikechi Okpechi; Justin B Echouffo-Tcheugui; Andre Pascal Kengne
Journal:  BMJ Glob Health       Date:  2017-05-29

7.  The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon.

Authors:  Badreldin H Ali; Turan Karaca; Yousuf Al Suleimani; Mohammed Al Za'abi; Jamila Al Kalbani; Mohammed Ashique; Abderrahim Nemmar
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

Review 8.  Pregnancy in Chronic Kidney Disease: Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Different CKD Stages and Phases.

Authors:  Giorgina B Piccoli; Elena Zakharova; Rossella Attini; Margarita Ibarra Hernandez; Alejandra Orozco Guillien; Mona Alrukhaimi; Zhi-Hong Liu; Gloria Ashuntantang; Bianca Covella; Gianfranca Cabiddu; Philip Kam Tao Li; Guillermo Garcia-Garcia; Adeera Levin
Journal:  J Clin Med       Date:  2018-11-05       Impact factor: 4.241

9.  Socioeconomic Deprivation Status and Air Pollution by PM10 and NO2: An Assessment at Municipal Level of 11 Years in Italy.

Authors:  Alice Mannocci; Immacolata Ciarlo; Valeria D'Egidio; Angela Del Cimmuto; Maria de Giusti; Paolo Villari; Giuseppe La Torre
Journal:  J Environ Public Health       Date:  2019-01-03

Review 10.  Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases.

Authors:  Giorgina Barbara Piccoli; Elena Zakharova; Rossella Attini; Margarita Ibarra Hernandez; Bianca Covella; Mona Alrukhaimi; Zhi-Hong Liu; Gloria Ashuntantang; Alejandra Orozco Guillen; Gianfranca Cabiddu; Philip Kam Tao Li; Gulliermo Garcia-Garcia; Adeera Levin
Journal:  J Clin Med       Date:  2018-10-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.